Progression to overt nephropathy in type 2 diabetes: The Casale Monferrato study

Diabetes Care

Volumn 26, Issue 7, 2003, Pages 2150-2155

  Bruno, Graziella ^a   Merletti, Franco ^b   Biggeri, Annibale ^c   Bargero, Giuseppe ^d   Ferrero, Stefania ^a   Pagano, Gianfranco ^a   Perin, Paolo Cavallo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d Ospedale S Spirito Casale Monferrato   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; FIBRINOGEN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; REGRESSION ANALYSIS; SYSTOLIC BLOOD PRESSURE; ALBUMINURIA; BLOOD; CLINICAL TRIAL; FEMALE; FOLLOW UP; MALE; METABOLISM; MULTICENTER STUDY; PATHOPHYSIOLOGY; PATIENT SELECTION; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; TIME; URINE;

AGED; ALBUMINURIA; APOLIPOPROTEINS B; BIOLOGICAL MARKERS; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; FIBRINOGEN; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; MALE; PATIENT SELECTION; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; SMOKING; TIME FACTORS;

EID: 1042299430     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.7.2150     Document Type: Article

References (28)

1. Ritz E, Rychlik I, Locatelli F, Halimi S: End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis 34:795-808, 1999
2. Raine AEG: Epidemiology, development and treatment of end-stage renal failure in type 2 (non-insulin-dependent) diabetic patients in Europe. Diabetologia 36:1099-1104, 1993
3. Remuzzi G, Schieppati A, Ruggenenti P: Nephropathy in patients with type 2 diabetes. N Engl J Med 346:1145-1151, 2002
4. Parving HH, Chaturvedi N, Viberti G, Mogensen CE: Does microalbuminuria predict diabetic nephropathy? Diabetes Care 25:406-407, 2002
5. Tabei BP, Al Kassab AS, Hag LL, Zawacki CM, Herman WH: Does microalbuminuria predict diabetic nephropathy? Diabetes Care 24:1560-1566, 2001
6. Caramori ML, Fioretto P, Mauer M: The need for early predictors of diabetic nephropathy risk. Is albumin excretion rate sufficient? Diabetes 49:1399-1408, 2000
7. Bonnet F, Cooper ME: Potential influence of lipids in diabetic nephropathy: insights from experimental data and clinical studies. Diabete Metab 26:254-264, 2000
8. Shoji T, Emoto M, Kawagishi T, Kimoto E, Yamada A, Tabata T, Ishimura E, Inaba M, Okuno Y, Nishizawa Y: Atherogenic lipoprotein changes in diabetic nephropathy. Atherosclerosis 156:425-433, 2001
9. Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R: Main risk factors for diabetic nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med 158:998-1004, 1988
10. Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med 310:356-360, 1984
11. Nelson RG, Bennett PH, Beck GJ, Tan M, Knowler WC, Mitch WE, Hirschman GH, Myers BD: Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. N Engl J Med 335:1636-1642, 1996
12. Klein R, Klein BEK, Moss SE, Cruickshanks: Ten-year incidence of gross proteinuria in people with diabetes. Diabetes 44:916-923, 1995
13. Yokoyama H, Okudaira M, Otani T, Watanabe C, Takaike H, Miuira J, Yamada H, Mutou K, Satou A, Uchigata Y, Iwamoto Y: High incidence of diabetic nephropathy in early-onset Japanese NIDDM patients: risk analysis. Diabetes Care 21:1080-1085, 1998
14. Bruno G, Cavallo-Perin P, Bargero G, Borra M, Calvi V, D'Errico N, Deambrogio P, Pagano G: Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of non-insulin-dependent diabetic subjects. Diabetes Care 19:43-47, 1996
15. Bruno G, Cavallo-Perin P, Bargero G, Borra M, D'Errico N, Pagano G: The associations of fibrinogen with glycemic control and albumin excretion rate in patients with non-insulin-dependent diabetes. Ann Intern Med 125:653-657, 1996
16. Bruno G, Cavallo-Perin P, Bargero G, Borra M, D'Errico N, Pagano G: Glycaemic and cardiovascular risk factors in type 2 (non-insulin-dependent) diabetes: a population-based study. Diabet Med 15: 304-307, 1998
17. Bruno G, Bargero G, Pisu E, Vuolo A, Pagano G: A population-based prevalence survey of known diabetes based upon multiple independent data sources of ascertainment. Diabetologia 35:851-856, 1992.
18. Bruno G, Cavallo-Perin P, Bargero G, Borra M, D'Errico N, Macchia G, Veglio M, Pagano G: Cardiovascular risk profile of type 2 diabetic patients cared for by general practitioners or by a diabetes clinic: a population-based study. J Clin Epidemiol 52:413-417, 1999
19. Bruno G, LaPorte R, Merletti F, Biggeri A, McCarty D, Pagano G: National diabetes programmes: application of capture-recapture to "count" diabetes? Diabetes Care 17:548-556, 1994
20. Garancini MP: L'epidemiologia del diabete non-insulino-dipendente e della ridotta tollemza al glucosio. In Il Diabete in Italia. Milano, Kurtis ED, 1996, p. 17-30
21. Prineas RT, Crow RS, Blackburn H: The Minnesota Code Manual of Electrocardiographic Findings. Minneapolis, Minnesota, Laboratory of Physiological Hygiene, School of Public Health, University of Minnesota, 1982
22. Simon R: Length biased sampling in etiologic studies. Am J Epidemiol 111:444-452, 1980
23. Fagot-Campagna A, Nelson RG, Knowler WC, Pettitt DJ, Robbins DC, Go O, Welty TK, Lee ET, Howard BV: Plasma lipoproteins and the incidence of abnormal excretion of albumin in diabetic American Indians: The Strong Heart Study. Diabetologia 41:1002-1009, 1998
24. Valmadrid CT, Klein R, Moss SE, Klein BE: The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 160:1093-1100, 2000
25. Chaturvedi N, Stephenson JM, Fuller JH: The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study. Diabetes Care 18:785-792, 1995
26. Pinto-Sietsma S-J, Mulder J, Janssen WMT, Hillege HL, de Zeeuw D, de Jong P: Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med 133:585-591, 2000
27. Chistensen PK, Larsen S, Horn T, Olsen S, Parving H-H: Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy. Kidney Int 58:1719-1731, 2001
28. Nosadini R, Velussi M, Brocco E, Bruseghin M, Abaterusso C, Saller A, Dalla Vestra M, Carraro A, Bortoloso E, Sambataro M, Barzon I, Frigato F, Muollo B, Chiesura-Corona M, Pacini G, Baggio B, Piarulli F, Sfriso A, Fioretto P: Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes 49:476-484, 2000